News

「CPHI Japan 2026(April 21-23)」Exhibition Information

SPERA PHARMA will exhibit at CPHI Japan 2026, held at Tokyo Big Sight from April 21 to 23, 2026. ★CPHI Japan 2026★    Date   : April 21-23, 2026    Venue: Booth 1A-41, East Hall 5, Tokyo Big Sig...

[Research Achievement] Research result on a novel [2+2+1] radical annulation reaction enabled by 3D ED/MicroED have been published (Joint Research with Meiji Pharmaceutical University)

A co-authored research paper by Keiyo Nakai and Mitsuhisa Yamano (SPERA PHARMA), together with Professor Nozomi Saito and Professor Masanori Tayu of Meiji Pharmaceutical University, has been published in The J...

[Research Achievement] Revolutionizing Nitrosamine Risk Mitigation: Direct Structure Determination with 3D ED / MicroED (Joint Research with Rigaku Corporation)

A new research paper authored by Keiyo Nakai, Kuniyoshi Miki, Natsuki Hashimoto, Mitsuhisa Yamano, et al., has been published in Org. Process Res. Dev. 2025 (ASAP).   Journal:   Org. Process Res. ...

A new research paper authored by Keiyo Nakai, Kuniyoshi Miki, Atsushi Kaga, Ryo Anzai, Mitsuhisa Yamano, et al., has been published in Crystal Growth & Design.   Journal:   Crystal Growth &amp...

PDF download SPERA PHARMA, Inc. (headquarters: Osaka; President and Representative Director: Keitaro Iwaki; hereinafter “SPERA PHARMA”), today announced a strategic alliance with Mycenax Biotech Inc. (headq...

SPERA PHARMA is pleased to announce our participation in BioJapan 2025. ★Bio Japan 2025    DATE: October 8 - 10, 2025    VENUE: PACIFICO Yokohama    Booth No.: A-34             ※ Please note t...

SPERA PHARMA is pleased to announce our participation in the upcoming KOREA LIFE SCIENCE WEEK 2025 (KOLS2025).   ★KOREA LIFE SCIENCE WEEK 2025    DATE: September 30- October 1, 2025    VENUE...

We are pleased to announce that researchers from SPERA PHARMA (Chemical R&D Laboratory) —Keiyo Nakai, Takahiro Konishi, Mitsuhisa Ymano, and Kuniyoshi Miki—will present their research findings in a poster ...

We are pleased to announce that Keiyo Nakai, Ph.D from SPERA PHARMA (Chemical R&D Laboratory) and Professor Takahiro Jomori from the University of the Ryukyus will present the results of their collaborativ...

SPERA PHARMA is pleased to announce our participation in the upcoming 15th American Drug Delivery & Formulation (DDF) Summit, taking place at The Westin Copley Place, Boston, USA, from September 15 to 16, ...

MORE

now loading.

page top